| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.46B | +5.3% |
| Cost of Revenue | $1.42B | +0.5% |
| Gross Profit | $1.04B | +12.8% |
| R&D Expense | $63.0M | -7.5% |
| SG&A Expense | $628.8M | +5.4% |
| Operating Income | $343.9M | +98.1% |
| Pre-tax Income | $287.7M | +122.9% |
| Income Tax | $44.8M | +244.6% |
| Net Income | $244.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $359.4M | +24.2% |
| Accounts Receivable | $439.6M | -4.8% |
| Inventory | $246.2M | -17.6% |
| Current Assets | $1.27B | +6.1% |
| Total Assets | $4.87B | -2.0% |
| Current Liabilities | $379.7M | +2.8% |
| Long-term Debt | $1.84B | -5.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $68.4M | +29.8% |
| Investing Cash Flow | -$73.8M | +70.5% |
| Financing Cash Flow | -$206.6M | -252.0% |
| +106.8% |
| EPS (Basic) | $1.01 | +106.1% |
| EPS (Diluted) | $1.01 | +106.1% |
| Total Liabilities |
| $2.48B |
| -5.9% |
| Stockholders' Equity | $2.38B | +2.3% |